Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly

Core Viewpoint - Stanley Druckenmiller, a renowned investor, has achieved significant returns without holding major AI stocks like Nvidia, Palantir, and Eli Lilly, indicating a strategic shift in his investment approach [1][2]. Group 1: Investment Strategy - Druckenmiller's portfolio has shown a 9.07% increase in Q3 2025, with 62 holdings, reflecting a diversified investment strategy [1]. - His top holdings are not concentrated in AI stocks, with Taiwan Semiconductor being his only AI investment, suggesting a unique approach compared to other hedge funds [2]. Group 2: Nvidia (NVDA) - Druckenmiller began acquiring Nvidia shares in late 2022 but sold his last shares in Q3 2024 when the stock was nearly $135, indicating a strategic exit as the stock price increased [4]. - Despite Nvidia's current price of $178, Druckenmiller's decision to sell appears to be based on valuation concerns and the identification of better investment opportunities [5]. Group 3: Palantir (PLTR) - Druckenmiller has had a fluctuating relationship with Palantir, selling over half his shares in Q3 2021, then re-entering in early 2022, and ultimately selling 94.6% of his holdings by Q3 2024 [6][7]. - Although he missed out on Palantir's gains, his strategy to shift into "safer" stocks with greater upside potential has proven effective, as his top holdings have outperformed Palantir significantly [8][10]. Group 4: Eli Lilly (LLY) - Druckenmiller has a history of trading Eli Lilly, having bought shares in 2022 and selling all holdings by Q3 2025, realizing substantial profits [11][12]. - His re-entry into Eli Lilly in Q4 2024 was followed by a complete exit in Q3 2025, coinciding with a price drop from the $900s to the $700s, but he missed subsequent gains as the stock rose to $1,054 [12][13].